Gay sex investors, what do we think about BioNTech? They've been developing a mRNA vaccine called BNT166 since 9/2023 and their phase 1/2 clinical trial has a primary completion date of 10/2024. Seems to me BNTX could take some of Bavarian Nordic's market share if the outbreak continues to get worse and BVNRY can't keep up with global demand. Africa alone is saying they need 10 million vaccines and BVNRY can only supply 2 million this year. Add on top of that, new orders from Europe, Asia and NA when/if cases start emerging in the coming weeks
>https://cepi.net/biontech-and-cepi-announce-partnership-advance-mrna-mpox-vaccine-development-and-support-cepis-100>https://clinicaltrials.gov/study/NCT05988203?term=NCT05988203&rank=1 